The UPMC Heart and Vascular Institute will be well-represented at the American Heart Association’s Scientific Sessions in New Orleans on Saturday, Nov. 12 – Wednesday, Nov. 16. Faculty research will be presented in both oral and abstract presentations.

November 13, 2016

511 – The Role Of Exposure To Environmental Pollutants In Racial Disparity In Cardiovascular Risk Factors And Novel Markers

Presented by: Sebhat Erqou, Jane Clougherty, Steven Reis

553 – Population Based Characterization of the Definition, Prevalence and Associated Mortality of Pulmonary Hypertension in the Setting of Left Heart Disease

Presented by: Rebecca R. Vanderpool, Melissa I. Saul, Seyed Mehdi Nouraie, Mark T. Gladwin, Marc A. Simon

 S4127 / 4127 – Trends in Heart Failure Hospitalizations Using Data From National Hospital Discharge Survey

Presented by: Muhammad Bilal Munir, Michael S. Sharbaugh, Floyd W. Thoma, Muhammad Umer Nisar, Amir S. Kamran, Andrew D. Althouse, Samir Saba

Advances in Contrast Echocardiography, Molecular and Myocardial Imaging

S4217 / 4217 – Targeted Delivery of AntimiR-23a Using Ultrasound and Microbubbles Suppresses Cardiac Hypertrophy and Improves Cardiac Function in vivo

Presented by: Jonathan A Kopechek, Charles F. McTiernan, Xucai Chen, Rafey Feroze, Bin Qin, Jissy Cyriac, Linda Lavery, Daniel Whitehurst, Flordeliza S. Villanueva

Clinical Applications of Nuclear Cardiology

S4251 / 4251 – Assessment of Dyssynchrony as an Indicator of Right Ventricular Free Wall Function by Gated Blood Pool SPECT (GBPS) in Patients undergoing LVAD Implantation

Presented by: Aditi Nayak, Christopher B. Link, Andrew D. Althouse, Robert L. Kormos, Marc A. Simon, Jeffrey J. Teuteberg, Luigi G. Lagazzi, Prem Soman

November 14, 2016

Metabolic Disease and Pulmonary Hypertension

670 – Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure With Preserved Ejection Fraction (PH-HFpEF)

Presented by: Yen-Chun Lai, Qingqing Meng, Neil Kelly, Marta Bueno, Jeffery Baust, Timothy Bachman, Rebecca Vanderpool, Josiah Radder, Jian Hu, Alison Morris, Ana Mora, Mark T. Gladwin

Imaging the Mitral Valve and Strain Imaging

M5020 / 5020 – Vector Flow Mapping Quantification of Left Ventricular Energy Loss Occurring in Normal Subjects

Presented by: Masataka Sugahara, Zhi Qi, Tijmen Koopsen, Marc A. Simon, John Gorcsan lll

Imaging the Right Heart and the Left Ventricle in Mitral Regurgitation

M5027 / 5027 – Three Dimensional Echocardiographic Wall Motion Tracking Assessment of Right Ventricular Remodeling and Effects on Left Ventricular Function as Prognostic Predictors in Patients With Pulmonary Hypertension

Presented by: Masataka Sugahara, Zhi Qi, Marc A. Simon, Michael A. Mathier, John Gorcsan lll

 Percutaneous Non-Coronary Cardiac Intervention (including Percutaneous Valves) III

M5078 / 5078 – Predictors of Mortality in Patients With Persistent Pulmonary Hypertension Following Transcatheter Aortic Valve Replacement

Presented by: Ahmad Masri, Michael S. Sharbaugh, Andrew D. Althouse, Islam Abdelkarim, Wei Han, William E. Katz, Frederick Crock, Mathew Harinstein, Dustin E. Kliner, Forozan Navid, Thomas G. Gleason, Joon S. Lee, John T. Schindler, João L. Cavalcante

Percutaneous Non-Coronary Cardiac Intervention (including Percutaneous Valves) III

M5081 / 5081 – Prognostic Value of Baseline Right Ventricular Dysfunction in Patients Undergoing Transcatheter Aortic Valve Replacement

Presented by: Islam Abdelkarim, Wei Han, Floyd Thoma, Andrew D Althouse, William E Katz, Frederick W Crock, Matthew E Harinstein, Dustin E Kliner, Forozan Navid, Thomas G Gleason, Joon S Lee, John T Schindler, João L Cavalcante

 Arrhythmia: Clinical Electrophysiology, Diagnosis and Risk Stratification V

M5186 / 5186 – Depression and 5-Year Stroke Risk in Patients With Atrial Fibrillation

Presented by: Bruno B. Lima, Andrew D. Althouse, Muhammad B. Munir, Michael S. Sharbaugh, Bruce L. Rollman, Samir Saba

 

Treatment of Arrhythmias: ICD/Pacemaker – excluding CRT II

M5276 / 5276 – Reversible Cause of Sudden Cardiac Arrest and Rates of Defibrillator Implantation

Presented by: Adetola Ladejobi, Deepak Kumar Pasupula, Shantanu Patil, Shasank Rijal, Bilal Munir, Asad Durrani, Awais Javed, Max Wayne, Oluremi Ajala, Natasha A. Kassim, Shubash Adhikari, Samir Saba

 

Ventricular Function/Hemodynamics and Biomarkers III

M4257 / 4257 – Myocardial Fibrosis is Associated With Pulmonary Artery Pressure and Adverse Outcomes in Patients With Preserved Left Ventricular Systolic Function

Presented by: George Cater, Erik Schelbert, Marc A. Simon, Peter Kellman, Timothy Wong

 

November 15, 2016

Echocardiography in Clinical Syndromes: CAD, Stress Echo, Vascular Disease

Echocardiographic Radial and Circumferential Strain Follow-up Analysis of Neurocardiac Injury in Patients With Subarachnoid Hemorrhage

Presented by: Zhi Qi, Masataka Sugahara, Elizabeth A. Crago, Yugang Chang, Theodore F. Lagattuta, Khalil Yousef, Robert M. Friedlander, Marilyn T. Hravnak, John Gorcsan III

 

Medical Aspects End Stage Heart Failure: Transplantation and Device Therapies IV

T4071 / 4071 – Critical Preoperative Factors and Specific Postoperative Adverse Events Drive Left Ventricular Assist Device Implant Hospitalization Costs

Presented by: Christine V. Nikas, Jennifer O. Larsen, Jeffrey J. Teuteberg, Luigi G. Lagazzi, Andrew D. Althouse, Michael S. Sharbaugh, Michael A. Shullo, Kathleen L. Lockard, Elizabeth M. Dunn, Nicole M. Kunz, Robert L. Kormos

 

770 – Heart Failure Admissions Under Observation versus Short Inpatient Stay: A Cohort Study

Presented by: Ahmad Masri, Andrew D. Althouse, Jeffrey McKibben, Floyd Thoma, Michael A. Mathier, Ravi Ramani, Jeffrey J. Teuteberg, Oscar C. Marroquin, Joon S. Lee, Suresh R. Mulukutla

 

VA.RFO.14 – Novel Insights into the Clinical Spectrum of PH and PAH

819 – Identification of a Pro-Hypertrophic Pathway With Chamber Specificity for the Right Ventricle; Implications for Right-Heart Dysfunction in Pulmonary Arterial Hypertension

Presented by: Imad Al Ghouleh, Daniel Meijles, John Sembrat, Mauricio Rojas, Rebecca R. Vanderpool, Jeffrey Baust, Asma Naqvi, Patrick J. Pagano,

 

Determinants of Clinical Outcome in Pulmonary Artery Hypertension

T4261 / 4261 – Nitric Oxide Synthase (NOS3) Asp298Glu Polymorphism and Survival in Pulmonary Arterial Hypertension

Presented by: Andrew Klein, David Ishizawar, Karen Hanley-Yanez, Dennis M. McNamara

 

For more information, visit the event website.